CN Stock MarketDetailed Quotes

002262 Jiangsu Nhwa Pharmaceutical

Watchlist
  • 27.25
  • +2.25+9.00%
Market Closed Sep 30 15:00 CST
27.69BMarket Cap24.71P/E (TTM)

Jiangsu Nhwa Pharmaceutical Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Jiangsu Nhwa Pharmaceutical Q2 2024 Earnings Date

Currency：CNYJul 31, 2024

Estimate
(YoY)		 Actual
(YoY)		 Vs Estimate
(% Chg)
Revenue
1.42B
1.41B
-14.79M
Miss Est.
+16.30%
+15.09%
-1.04%
Net Income
--
361.93M
--
+13.38%
Analyst Rating
Strong Buy

Sep 30, 2024

Jiangsu Nhwa Pharmaceutical Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 2 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: CNY

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
--2024/Q4-- / 1.625B--
Oct 26, 20242024/Q3-- / 1.463B--
Jul 31, 20242024/Q21.406B / 1.421B--
Apr 20, 20242024/Q11.358B / 1.380B--
Mar 30, 20242023/Q41.386B / 1.374B--
DatePeriodRevenue/EstimateEarnings Call
--2024/Q4-- / 1.625B--
Oct 26, 20242024/Q3-- / 1.463B--
Jul 31, 20242024/Q21.406B / 1.421B--
Apr 20, 20242024/Q11.358B / 1.380B--
Mar 30, 20242023/Q41.386B / 1.374B--

Unlock Free Earnings Estimates

Jiangsu Nhwa Pharmaceutical Earnings Reports

  • Jiangsu Nhwa Pharmaceutical: Half-year report for the year 2024.

    Jul 30 12:00 ET

  • Jiangsu Nhwa Pharmaceutical: Summary of Half-Year Report in 2024.

    Jul 30 12:00 ET

  • Enhua Pharmaceutical: Report for the first quarter of 2024

    Apr 19 12:00 ET

  • Enhua Pharmaceutical: 2023 Annual Report Summary

    Mar 29 12:00 ET

    • Read more

    Analysis

    Analyst Rating

    Updated: Sep 30, 2024

    Strong Buy

    • Strong Buy

      84.62%

    • Buy

      15.39%

    • Hold

      0.00%

    • Underperform

      0.00%

    • Sell

      0.00%

    Price Target

    No Data

    Heat List
    CN
    Overall
    Symbol
    Latest Price
    % Chg

    No Data